Effects of Continuous Anterior Chest Compression
StrapVent
" Effects of Continuous Anterior Chest Compression (CACC) & Comparision With Prone Position in ARDS Patients " The StrapVent Study "
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim is to test the physiological effects of continuous anterior chest compression in patients with severe to moderate ARDS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 13, 2022
CompletedFirst Submitted
Initial submission to the registry
August 8, 2022
CompletedFirst Posted
Study publicly available on registry
May 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2023
CompletedFebruary 11, 2026
January 1, 2026
1.2 years
August 8, 2022
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The end inspiratory transpulmonary pressure (PL-insp) in centimetre of water
The transpulmonary pressure will be measured by using an esophageal catheter connected to a differential pressure transducer. The PL-insp will be calculated using the ratio between the elastance of the lung (El) and of the respiratory system (Ers) expressed in centimetre of water thanks to this formula PL-insp = Plateau pressure x (El/Ers). The PL-insp between the different protocol conditions will be compared (After 16 hours of prone position, in supine position, 15mn after CACC with a pressure equal to the one observed in the prone position, 15mn after CACC with a pressure set at 60 - 80 cmH20, 15mn after taking off the CACC in supine position ). CACC will be considered protective if there is a decrease in Pl-insp.
Through study completion (up to 6 hours)
Secondary Outcomes (8)
Regional pulmonary compliances in centimetre of water
Through study completion (up to 6 hours)
Lung mechanics : Airways pressure, Flow curves and Esophageal pressure
Through study completion (up to 6 hours)
Pulmonary ventilation distribution in percentage
Through study completion (up to 6 hours)
Recruitment-to-inflation (R/I) ratio
Through study completion (up to 6 hours)
Hemodynamics
Through study completion (up to 6 hours)
- +3 more secondary outcomes
Study Arms (1)
A description of each arm of the clinical trial that indicates its role in the clinical trial
EXPERIMENTALArm 1 Description: The study will consitent of recording the measurments of ventilatory settings, respiratory mechanics, flow and pressure curves, gaz exchange, haemodynamics and ventilation distribution in 5 consecutive conditions in adult patients with moderate to severe ARDS : * After 16 hours of prone position * In supine position 1 hour after the prone position * 15mn after CACC with a pressure equal to the one observed in the prone position * 15mn after CACC with a pressure set at 60 - 80 cmH20 * 15mn after taking of the CACC
Interventions
Patients with severe to moderate ARDS who were placed in prone position by the attending physician : * First CACC : the applied pressure is equal to the one observed in the prone position * Second CACC : The applied pressure is set at 60 - 80 cmH20
Eligibility Criteria
You may qualify if:
- Age ≥ 18 ans
- Intubated moderate and severe ARDS according to the Berlin definition (PaO2/FiO2 ratio \<= 200 mmHg)
- The patent must be sedated and paralyzed
- Informed consent from patient or family members
You may not qualify if:
- Extracorporeal membrane oxygenation (ECMO)
- Pneumothorax
- Thoracic trauma during the last 3 months
- Refractory shock
- Contraindication to EIT monitoring (e.g. burns, pacemaker, thoracic wounds limiting electrode belt placement)
- Pregnancy
- Any contra-indication to esophageal manometry (less than one month esophagus surgery, bronchopleural or esotracheal fistula, latex allergy)
- No social care
- Adults under Guardianship, curatorship or protection of the court
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR
Créteil, 94010, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume CARTEAUX, MD, PhD
APHP
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2022
First Posted
May 25, 2023
Study Start
April 13, 2022
Primary Completion
June 25, 2023
Study Completion
June 25, 2023
Last Updated
February 11, 2026
Record last verified: 2026-01